Concepedia

Michael Serzan

MS

5

Publications

127

Citations

5

H-Index

2021

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Georgetown Lombardi Comprehensive Cancer Center

Georgetown University

Georgetown University Medical Center

Cornell University

Michael Serzan is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, surgical oncology, and immunotherapy.

ORCID

Top concepts

Publications per year

2021–2024

5

Publications

5

Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis

Dongyu Zhang, Neil J. Shah, Michael Cook et al. · Cancers · 2021 · 38 citations · Full text

Current and emerging therapies for first line treatment of metastatic clear cell renal cell carcinoma

Michael Serzan, Michael B. Atkins · Journal of Cancer Metastasis and Treatment · 2021 · 37 citations · Full text

, , +17

The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring Steroids

Neil J. Shah, Michael Cook, Tianmin Wu et al. · Journal of the National Comprehensive Cancer Network · 2022 · 25 citations · Full text

The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real‐world, multicenter, retrospective study

Shaked Lev‐Ari, Michael Serzan, Tianmin Wu et al. · Cancer · 2023 · 15 citations · Full text

Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials

Neil J. Shah, Alexandra Della Pia, Tianmin Wu et al. · Cancers · 2024 · 12 citations · Full text

Rows per page

1–5 of 5